Please wait a minute...

本期目录

    2019年, 第14卷, 第4期 刊出日期:2019-12-20 上一期    下一期
    An Empirical Research on the Relationship of Market Structure, Efficiency and Performance of Chinese Traditional Patent Medicine Industry
    Gao Yongbo, Cao Linlin, Xiao Yao, Sun Lihua
    2019 (4):  155-164. 
    摘要 ( 412 )   PDF(1185KB) ( 557 )  
    Objective To explore the relationship of market structure, efficiency and performance of Chinese traditional patent medicine (CTPM) industry, and to provide suggestions for the government and related enterprises to take the corresponding strategies. Methods Econometric model were empirically analyzed about 44 ongoing sample enterprises from 2007 to 2017, based on market power hypothesis and efficiency structure hypothesis of the industrial organization theory. Results and Conclusion The CTPM industry and the unlisted enterprises only conform to the relative market power hypothesis, and there is a significant positive correlation between performance and market share. The listed enterprises do not conform to the market power hypothesis and efficiency structure hypothesis: There is no significant correlation between performance and efficiency, market structure. There is no significant correlation between market share and efficiencies, while the industrial concentration has a significant correlation with efficiencies. The CTPM industry is relatively immature, so it’s necessary for the government to establish the elimination mechanism of CTPM industry in line with market rules, to enhance the industrial concentration and resource utilization efficiency by encouraging enterprises to improve management and scale production level. The government should improve the innovation policy of CTPM industry to encourage the enterprises to pursue product innovation. The CTPM enterprises, especially the unlisted enterprises should increase the market shares and enterprise performance through production differentiation.
    相关文章 | 计量指标
    Analysis of the Reference Preparations of 289 List for the Consistency Evaluation for Generic Drugs
    Cheng Yuan, Tian Lijuan
    2019 (4):  165-173. 
    摘要 ( 457 )   PDF(780KB) ( 382 )  
    Objective To study whether the reference preparations of 289 list are determined and to analyze why some reference preparations are not put on file, and suggestions are raised for follow-up work. Methods Selection principles, situations of filing and releasing of reference preparations were clarified, 289 listed items were classified and each reference preparation was discussed respectively. Results and Conclusion Reference preparations of 289 list were determined basically. Up to February 2018, 42 drugs had not been put on file, 18 of which had no other dosage form of same generic names filing at the same time. Besides, 4 of these 18 varieties had been removed from the National Essential Medicine List. The clinical alternatives of the remaining 14 varieties should be further evaluated so as to avoid the cases that the low-cost drugs will be removed from the National Essential Medicine List due to failure of consistency evaluation. Meanwhile, those irrational dosage forms that cannot pass the consistency evaluation should be removed from the National Essential Medicine List gradually.
    相关文章 | 计量指标
    Innovative Development of Bio-Pharmaceutical Industry in Liaoning Province from the Perspective of Patent Data
    Wu Yakun, Yuan Hongmei
    2019 (4):  174-184. 
    摘要 ( 366 )   PDF(937KB) ( 380 )  
    Objective To study the innovation and cooperation of bio-pharmaceutical industry in Liaoning Province and to provide some suggestions for the government to formulate innovation policies for the development of this industry. Methods Comparative analysis and social network analysis methods were applied to conduct an empirical analysis of industrial innovative development based on the patent data of bio-pharmaceuticals for nearly 10 years. Results and Conclusion The number of patents in bio-pharmaceutical industry in Liaoning Province is on the rise overall, but it slowed down in recent years. The status of research institutions and universities in innovative cooperation is high, but the overall cooperation among them is relatively loose. In order to promote the innovation and development of bio-pharmaceutical industry in Liaoning, it is necessary to take it as a pillar industry. Meanwhile, importance should be attached to the protection of innovative patents of companies, and industrial clusters should be actively built to promote synergy within the industry
    相关文章 | 计量指标
    Patent Applications of Pharmaceutical Industry in Liaoning: Current Situation and Suggestions
    Zhao Zhe, Sheng Mengdi, Fan Junyan, Liu Yanwen, Dong Li
    2019 (4):  185-191. 
    摘要 ( 410 )   PDF(768KB) ( 428 )  
    Objective To analyze the current situation of pharmaceutical patents in Liaoning Province with the background of increasing emphasis on intellectual property rights in the pharmaceutical industry and the application of pharmaceutical-related patents having taken shape in Liaoning Province. Methods The invention patent information applied by Liaoning pharmaceutical manufacturers before December 31, 2018 was obtained from Qixinbao APP, and then the retrieval data was also obtained through detailed search on patent information inquiry websites in China and other countries. The types of drug patents were separately extracted by Excel. Data analysis was carried out according to drug category, applicant type, legal status and transfer situation. Results and Conclusion A thorough discussion on the current situation of patent applications in pharmaceutical industry of Liaoning Province reveals that the number of patent applications is large but they are lack of creativity. Meanwhile, few patent applications are made by individual. Besides, there are fewer international patent applications for pharmaceutical patents in Liaoning Province. The problems in patent applications include the followings, such as insufficient patent applications and unbalanced proportion of patent applications. In order to promote the stable development of pharmaceutical market in Liaoning Province, some suggestions are raised
    相关文章 | 计量指标
    Development of Licensed Pharmacists in China: Dilemma and Opportunity
    De Xianhui, An Lianyu, Wang Shuling
    2019 (4):  192-203. 
    摘要 ( 396 )   PDF(1418KB) ( 452 )  
    Objective To study the current status of licensed pharmacists in China, and to make suggestions for the sound development of regulation authorities and licensed pharmacists. Methods Literature review and data research were conducted to analyze the status of examinations, registration, academic qualification and professional composition of licensed pharmacists. And SWOT method was used to analyze the strengths, weaknesses, opportunities and threats for the development of licensed pharmacists. Results and Conclusion Licensed pharmacists have such advantages and opportunities as professionalism, favorable policies, and continuous expansion of market demand. However, they also face disadvantages and threats, such as low service capacity, weak service awareness and low social status. According to the results of SWOT analysis, it is suggested that the government should make use of the advantages of artificial intelligence to build a regulatory information platform and a public platform for electronic prescriptions. Meanwhile, a national accreditation agency for continuing education should be established, and academic exchanges between regional licensed pharmacists and physicians must be organized regularly. Besides, licensed pharmacists can use mobile phones and other information devices to keep abreast of national policy and new medical information. Therefore, their services will be recognized by the public, thus to protect the drug safety for the public.
    相关文章 | 计量指标
    Pharmacoeconomic Study on the Treatment of Terminal Non-small Cell Lung Cancer with Icotinib and Pemetrexed Combined with Cisplatin
    Chai Dongye, Zhang Fang
    2019 (4):  204-208. 
    摘要 ( 429 )   PDF(752KB) ( 351 )  
    Objective To provide theoretical basis for clinical treatment of patients with terminal non-small cell lung cancer through the analysis of the cost and adverse reactions of the joint treatment of icotinib and pemetrexed combined with cisplatin. Methods The clinical data of the patients diagnosed with terminal non-small cell lung cancer were collected and analyzed according to different drug administration schedules (n = 53 of each group). The efficacy, cost and adverse reactions were evaluated respectively, aiming to provide the pharmacoeconomic evidence for the clinical applications. Results and Conclusion There was no significant difference between the efficacy of the icotinib group and the pemetrexed combined with cisplatin group, but the cost of the icotinib group was much lower, and the adverse reactions such as leukopenia, anemia, vomiting and nausea were far fewer than those in the pemetrexed combined cisplatin group. Although the two methods have similar therapeutic effects, the icotinib group has lower cost and fewer adverse reactions. Thus, from the perspective of pharmacoeconomics, icotinib has its advantage over the traditional regimen on the treatment of terminal non-small cell lung cancer.
    相关文章 | 计量指标
    Pharmaceutical WeChat Public Platform Based on PEST-SWOT Matrix Model: Current Status and Development Strategies
    Shi Ping, Wang Shuling
    2019 (4):  209-218. 
    摘要 ( 420 )   PDF(1009KB) ( 423 )  
    Objective To analyze of the status of pharmaceutical WeChat public platforms, and to put forward some suggestions for its future development. Methods PEST-SWOT matrix model for the pharmaceutical WeChat public platforms was constructed to sort out the strength, weakness, opportunities and threats of the platforms compared with the traditional health information communication media. Results and Conclusion Pharmaceutical WeChat public platform has such features as strong flexibility, high industrial sensitivity and wide communication resources. However, it has also the disadvantages of too general content and homogenization, unclearly positioning and single feedback path. From the perspective of SO, ST, WO and WT, the development strategy of pharmaceutical WeChat public platform is to offer accurate information with the big data to create new way of media thinking, to define its own positioning so as to provide vertical service, and to enhance its professionalism.
    相关文章 | 计量指标